1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Repurposed Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Generic Drugs
1.2.3 Clinical Trial Failed Drugs
1.3 Market by Application
1.3.1 Global Repurposed Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Cardiovascular Diseases
1.3.3 Mental Illness
1.3.4 Cancer
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Repurposed Drugs Market Perspective (2017-2028)
2.2 Repurposed Drugs Growth Trends by Region
2.2.1 Repurposed Drugs Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Repurposed Drugs Historic Market Size by Region (2017-2022)
2.2.3 Repurposed Drugs Forecasted Market Size by Region (2023-2028)
2.3 Repurposed Drugs Market Dynamics
2.3.1 Repurposed Drugs Industry Trends
2.3.2 Repurposed Drugs Market Drivers
2.3.3 Repurposed Drugs Market Challenges
2.3.4 Repurposed Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Repurposed Drugs Players by Revenue
3.1.1 Global Top Repurposed Drugs Players by Revenue (2017-2022)
3.1.2 Global Repurposed Drugs Revenue Market Share by Players (2017-2022)
3.2 Global Repurposed Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Repurposed Drugs Revenue
3.4 Global Repurposed Drugs Market Concentration Ratio
3.4.1 Global Repurposed Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Repurposed Drugs Revenue in 2021
3.5 Repurposed Drugs Key Players Head office and Area Served
3.6 Key Players Repurposed Drugs Product Solution and Service
3.7 Date of Enter into Repurposed Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Repurposed Drugs Breakdown Data by Type
4.1 Global Repurposed Drugs Historic Market Size by Type (2017-2022)
4.2 Global Repurposed Drugs Forecasted Market Size by Type (2023-2028)
5 Repurposed Drugs Breakdown Data by Application
5.1 Global Repurposed Drugs Historic Market Size by Application (2017-2022)
5.2 Global Repurposed Drugs Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Repurposed Drugs Market Size (2017-2028)
6.2 North America Repurposed Drugs Market Size by Type
6.2.1 North America Repurposed Drugs Market Size by Type (2017-2022)
6.2.2 North America Repurposed Drugs Market Size by Type (2023-2028)
6.2.3 North America Repurposed Drugs Market Share by Type (2017-2028)
6.3 North America Repurposed Drugs Market Size by Application
6.3.1 North America Repurposed Drugs Market Size by Application (2017-2022)
6.3.2 North America Repurposed Drugs Market Size by Application (2023-2028)
6.3.3 North America Repurposed Drugs Market Share by Application (2017-2028)
6.4 North America Repurposed Drugs Market Size by Country
6.4.1 North America Repurposed Drugs Market Size by Country (2017-2022)
6.4.2 North America Repurposed Drugs Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Repurposed Drugs Market Size (2017-2028)
7.2 Europe Repurposed Drugs Market Size by Type
7.2.1 Europe Repurposed Drugs Market Size by Type (2017-2022)
7.2.2 Europe Repurposed Drugs Market Size by Type (2023-2028)
7.2.3 Europe Repurposed Drugs Market Share by Type (2017-2028)
7.3 Europe Repurposed Drugs Market Size by Application
7.3.1 Europe Repurposed Drugs Market Size by Application (2017-2022)
7.3.2 Europe Repurposed Drugs Market Size by Application (2023-2028)
7.3.3 Europe Repurposed Drugs Market Share by Application (2017-2028)
7.4 Europe Repurposed Drugs Market Size by Country
7.4.1 Europe Repurposed Drugs Market Size by Country (2017-2022)
7.4.2 Europe Repurposed Drugs Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Repurposed Drugs Market Size (2017-2028)
8.2 Asia-Pacific Repurposed Drugs Market Size by Type
8.2.1 Asia-Pacific Repurposed Drugs Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Repurposed Drugs Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Repurposed Drugs Market Share by Type (2017-2028)
8.3 Asia-Pacific Repurposed Drugs Market Size by Application
8.3.1 Asia-Pacific Repurposed Drugs Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Repurposed Drugs Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Repurposed Drugs Market Share by Application (2017-2028)
8.4 Asia-Pacific Repurposed Drugs Market Size by Region
8.4.1 Asia-Pacific Repurposed Drugs Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Repurposed Drugs Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Repurposed Drugs Market Size (2017-2028)
9.2 Latin America Repurposed Drugs Market Size by Type
9.2.1 Latin America Repurposed Drugs Market Size by Type (2017-2022)
9.2.2 Latin America Repurposed Drugs Market Size by Type (2023-2028)
9.2.3 Latin America Repurposed Drugs Market Share by Type (2017-2028)
9.3 Latin America Repurposed Drugs Market Size by Application
9.3.1 Latin America Repurposed Drugs Market Size by Application (2017-2022)
9.3.2 Latin America Repurposed Drugs Market Size by Application (2023-2028)
9.3.3 Latin America Repurposed Drugs Market Share by Application (2017-2028)
9.4 Latin America Repurposed Drugs Market Size by Country
9.4.1 Latin America Repurposed Drugs Market Size by Country (2017-2022)
9.4.2 Latin America Repurposed Drugs Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Repurposed Drugs Market Size (2017-2028)
10.2 Middle East & Africa Repurposed Drugs Market Size by Type
10.2.1 Middle East & Africa Repurposed Drugs Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Repurposed Drugs Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Repurposed Drugs Market Share by Type (2017-2028)
10.3 Middle East & Africa Repurposed Drugs Market Size by Application
10.3.1 Middle East & Africa Repurposed Drugs Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Repurposed Drugs Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Repurposed Drugs Market Share by Application (2017-2028)
10.4 Middle East & Africa Repurposed Drugs Market Size by Country
10.4.1 Middle East & Africa Repurposed Drugs Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Repurposed Drugs Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Teva
11.1.1 Teva Company Details
11.1.2 Teva Business Overview
11.1.3 Teva Repurposed Drugs Introduction
11.1.4 Teva Revenue in Repurposed Drugs Business (2017-2022)
11.1.5 Teva Recent Developments
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Repurposed Drugs Introduction
11.2.4 Novartis Revenue in Repurposed Drugs Business (2017-2022)
11.2.5 Novartis Recent Developments
11.3 Mylan
11.3.1 Mylan Company Details
11.3.2 Mylan Business Overview
11.3.3 Mylan Repurposed Drugs Introduction
11.3.4 Mylan Revenue in Repurposed Drugs Business (2017-2022)
11.3.5 Mylan Recent Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Repurposed Drugs Introduction
11.4.4 Johnson & Johnson Revenue in Repurposed Drugs Business (2017-2022)
11.4.5 Johnson & Johnson Recent Developments
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Repurposed Drugs Introduction
11.5.4 Pfizer Revenue in Repurposed Drugs Business (2017-2022)
11.5.5 Pfizer Recent Developments
11.6 Bausch Health
11.6.1 Bausch Health Company Details
11.6.2 Bausch Health Business Overview
11.6.3 Bausch Health Repurposed Drugs Introduction
11.6.4 Bausch Health Revenue in Repurposed Drugs Business (2017-2022)
11.6.5 Bausch Health Recent Developments
11.7 GSK
11.7.1 GSK Company Details
11.7.2 GSK Business Overview
11.7.3 GSK Repurposed Drugs Introduction
11.7.4 GSK Revenue in Repurposed Drugs Business (2017-2022)
11.7.5 GSK Recent Developments
11.8 ChemRar Group
11.8.1 ChemRar Group Company Details
11.8.2 ChemRar Group Business Overview
11.8.3 ChemRar Group Repurposed Drugs Introduction
11.8.4 ChemRar Group Revenue in Repurposed Drugs Business (2017-2022)
11.8.5 ChemRar Group Recent Developments
11.9 Glenmark
11.9.1 Glenmark Company Details
11.9.2 Glenmark Business Overview
11.9.3 Glenmark Repurposed Drugs Introduction
11.9.4 Glenmark Revenue in Repurposed Drugs Business (2017-2022)
11.9.5 Glenmark Recent Developments
11.10 Fujifilm
11.10.1 Fujifilm Company Details
11.10.2 Fujifilm Business Overview
11.10.3 Fujifilm Repurposed Drugs Introduction
11.10.4 Fujifilm Revenue in Repurposed Drugs Business (2017-2022)
11.10.5 Fujifilm Recent Developments
11.11 Dr. Reddy
11.11.1 Dr. Reddy Company Details
11.11.2 Dr. Reddy Business Overview
11.11.3 Dr. Reddy Repurposed Drugs Introduction
11.11.4 Dr. Reddy Revenue in Repurposed Drugs Business (2017-2022)
11.11.5 Dr. Reddy Recent Developments
11.12 R-Pharma
11.12.1 R-Pharma Company Details
11.12.2 R-Pharma Business Overview
11.12.3 R-Pharma Repurposed Drugs Introduction
11.12.4 R-Pharma Revenue in Repurposed Drugs Business (2017-2022)
11.12.5 R-Pharma Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
